Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-26 @ 2:52 AM
Study NCT ID:
NCT00387894
Status:
TERMINATED
Last Update Posted:
2013-06-04
First Post:
2006-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Sponsor:
Michael Prados
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-12
First Submit QC Date:
None
Study First Post Date:
2006-10-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-04-12
Results First Submit QC Date:
None
Results First Post Date:
2013-05-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-25
Last Update Post Date:
2013-06-04
Last Update Post Date Type:
ESTIMATED